Optimizing Care Across the Continuum: Updates in the Detection and Treatment of Prostate Cancer - Episode 3

Data from the DEAR Real-World Study and Strategies for Optimizing Outcomes

,

Drs. Dorff and McKay discuss real-world data from DEAR trial comparing darolutamide, enzalutamide and apalutamide, providing clinical pearls on their experiences to optimize outcomes.